There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this book

Cited by 1

Cost–effectiveness of pembrolizumab for second-line treatment of esophageal squamous cell carcinoma patients with a combined positive score of 10 or more
Authors: Xiaobing Song, Zhiwei Zheng, Xiuli Li …

See all cited by

Guidelines of Chinese Society of Clinical Oncology (CSCO) Esophageal Cancer.

Read this book at

Related collections

Karger: Oncology

Comments

Comment on this book

Similar content 1,668

Cited by 1